Sponsor or institution
Clinical trials and research at Shenzhen Celconta Life Science Co., Ltd.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Shenzhen Celconta Life Science Co., Ltd. that are recruiting, in China. By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
PANK-003 cell injection with chemotherapy for solid tumors
This study is testing if PANK-003 cell injections combined with chemotherapy can help people who have had surgery for solid tumors like lung or breast cancer feel better and improve their chances of recovery.
-
Treatment for advanced solid tumors with Claudin18.2 using XKDCT225
This study is testing a new cell injection treatment for people with advanced solid tumors that have a specific marker, to see if it is safe and effective for those who haven't had success with other treatments.
Quick answers
How many clinical trials run by Shenzhen Celconta Life Science Co., Ltd. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.